Some of the key players operating in the global medical cannabis market include Medical Marijuana Inc., Aphria, Inc., Aurora Cannabis, Inc., MGC Pharmaceuticals Limited, Tilray, Medreleaf Corporation, BOL Pharma, Canopy Growth Corporation, Insys Therapeutics Inc. and GW Pharmaceuticals, plc.
Market Segmentation:
The medicinal cannabis market is segmented on the basis of point of sale, active ingredient, therapeutic application and geography. The point of sale segment is further bifurcated into dispensaries, online pharmacy and hospital pharmacy. On the basis of active ingredient, the market is classified into Tetrahydrocannabinol( THC) and Cannabidiol( CBD) whereas based on therapeutic application, the market is bifurcated into pain, arthritis, neurological disease neurological applications and other applications. Furthermore, neurological applications is segmented into epilepsy, multiple sclerosis and other neurological applications. Geographically, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Obtain Report Details with technological advancement at https:// www. xpodenceresearch. com / Reports / Medicinal- Cannabis-Market
Region Analysis:
The North America region is expected to dominate the market over the forecast year owing to legalization of Marijuana in U. S. In the U. S., manufacturers of Medicinal cannabis are focusing on expansion of their product business. For instance, in July 2016, Insys Therapeutics, Inc. received the U. S. Food and Drug Administration( FDA) approval for dronabinol oral solution- Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol is indicated to be used in the treatment of anorexia pertaining to AIDS and cancer chemotherapy-induced nausea and vomiting. Furthermore, in 2016, Medical Marijuana, Inc. launched the HempMeds Mexico which is a CBD hemp oil product and the company intends to expand its cannabis business in the Latin America.
The market in Middle Easter and Africa region is estimated to grow during the forecast period. Among the GCC countries, Israel has approved the medical cannabis product. In Africa region, the governments in Lesotho and Malawi in South Africa have granted the license for medicinal marijuana in 2017 and Verve Dynamics, a Cape Town-based alternative medicines company has received a license from the government of Lesotho to cultivate the cannabidiol( CBD) medicinal cannabis.
Major Points from Table of content:
• Executive Summary
• Research Methodology
• Market Dynamics
• Industry Overview
• Global Medicinal Cannabis Market, By Product( 2017-2025)
• Global Medicinal Cannabis Market, By Regions( 2017-2025)
• Market Competition Analysis
About Us:
Xpodence Research have the most extensive collection of market research reports of many categories. Xpodence Research provides the best market research solution for every industry by publishing the best possible results of great market